Filing Details
- Accession Number:
- 0001140361-18-012906
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-09 19:00:15
- Reporting Period:
- 2018-03-07
- Accepted Time:
- 2018-03-09 19:00:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1656328 | Sienna Biopharmaceuticals Inc. | SNNA | Pharmaceutical Preparations (2834) | 273364627 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1711463 | Todd Harris | C/O Sienna Biopharmaceuticals, Inc. 30699 Russell Ranch Road, Suite 140 Westlake Village CA 91362 | Head Of Corporate Development | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-03-07 | 3,704 | $20.00 | 628,362 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-08 | 14,530 | $20.03 | 613,832 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-03-09 | 2,438 | $20.01 | 611,394 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017.
- This transaction was executed in multiple trades in prices ranging from $20.00 to $20.28, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- This transaction was executed in multiple trades in prices ranging from $20.00 to $20.09, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Billionaire Hedge Funds
